Abstract
Genotoxicity is associated with serious health effects and includes different types of DNA lesions, gene mutations, structural chromosome aberrations involving breakage and/or rearrangements of chromosomes (referred to as clastogenicity) and numerical chromosome aberrations (referred to as aneuploidy). Assessing the potential genotoxic properties of chemicals, including nanomaterials (NMs), is a key element in regulatory safety assessment. State-of-the-art genotoxicity testing includes a battery of assays covering gene mutations, structural and numerical chromosome aberrations. Typically various in vitro assays are performed in the first tier. It is not very likely that NMs may induce as yet unknown types of genotoxic damage beyond what is already known for chemicals. Thus, principles of genotoxicity testing as established for chemicals should be applicable to NMs as well. However, established test guidelines (i.e., OECD TG) may require adaptations for NM testing, as currently under discussion at the OECD. This chapter gives an overview of genotoxicity testing of NMs in vitro based on experiences from various research projects. We recommend a combination of a mammalian gene mutation assay (at either Tk or HPRT locus), the in vitro comet assay, and the cytokinesis-block micronucleus assay, which are discussed in detail here. In addition we also include the Cell Transformation Assay (CTA) as a promising novel test for predicting NM-induced cell transformation in vitro.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Committee ES (2011) Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment. EFSA J 9(9):2379. https://doi.org/10.2903/j.efsa.2011.2379
Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V, Andersen KE, Angers-Loustau A, Aptula A, Bal-Price A, Benfenati E, Bernauer U, Bessems J, Bois FY, Boobis A, Brandon E, Bremer S, Broschard T, Casati S, Coecke S, Corvi R, Cronin M, Daston G, Dekant W, Felter S, Grignard E, Gundert-Remy U, Heinonen T, Kimber I, Kleinjans J, Komulainen H, Kreiling R, Kreysa J, Leite SB, Loizou G, Maxwell G, Mazzatorta P, Munn S, Pfuhler S, Phrakonkham P, Piersma A, Poth A, Prieto P, Repetto G, Rogiers V, Schoeters G, Schwarz M, Serafimova R, Tahti H, Testai E, van Delft J, van Loveren H, Vinken M, Worth A, Zaldivar JM (2011) Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010. Arch Toxicol 85(5):367–485. https://doi.org/10.1007/s00204-011-0693-2
Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajouji A, Glatt H, Hastwell P, Hayashi M, Kasper P, Kirchner S, Lynch A, Marzin D, Maurici D, Meunier JR, Muller L, Nohynek G, Parry J, Parry E, Thybaud V, Tice R, van Benthem J, Vanparys P, White P (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM workshop. Mutat Res 628(1):31–55. https://doi.org/10.1016/j.mrgentox.2006.11.008
Oesch F, Landsiedel R (2012) Genotoxicity investigations on nanomaterials. Arch Toxicol 86(7):985–994. https://doi.org/10.1007/s00204-012-0838-y
Pfuhler S, Elespuru R, Aardema MJ, Doak SH, Maria Donner E, Honma M, Kirsch-Volders M, Landsiedel R, Manjanatha M, Singer T, Kim JH (2013) Genotoxicity of nanomaterials: refining strategies and tests for hazard identification. Environ Mol Mutagen 54(4):229–239. https://doi.org/10.1002/em.21770
Warheit DB, Donner EM (2010) Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines. Nanotoxicology 4:409–413. https://doi.org/10.3109/17435390.2010.485704
OECD (2014) Genotoxicity of manufactured nanomaterials: report of the OECD expert meeting (ENV/JM/MONO(2014)34). http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2014)34&doclanguage=en
ECHA (2017) Appendix R7–1 for nanomaterials applicable to Chapter R7a—Endpoint specific guidance, v. 2.0, May 2017. https://echa.europa.eu/documents/10162/13632/appendix_r7a_nanomaterials_en.pdf
Donaldson K, Poland CA, Schins RP (2010) Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies. Nanotoxicology 4:414–420. https://doi.org/10.3109/17435390.2010.482751
Sood A, Salih S, Roh D, Lacharme-Lora L, Parry M, Hardiman B, Keehan R, Grummer R, Winterhager E, Gokhale PJ, Andrews PW, Abbott C, Forbes K, Westwood M, Aplin JD, Ingham E, Papageorgiou I, Berry M, Liu J, Dick AD, Garland RJ, Williams N, Singh R, Simon AK, Lewis M, Ham J, Roger L, Baird DM, Crompton LA, Caldwell MA, Swalwell H, Birch-Machin M, Lopez-Castejon G, Randall A, Lin H, Suleiman MS, Evans WH, Newson R, Case CP (2011) Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat Nanotechnol 6(12):824–833. https://doi.org/10.1038/nnano.2011.188
Magdolenova Z, Collins A, Kumar A, Dhawan A, Stone V, Dusinska M (2014) Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. Nanotoxicology 8(3):233–278. https://doi.org/10.3109/17435390.2013.773464
Doak SH, Dusinska M (2017) NanoGenotoxicology: present and the future. Mutagenesis 32(1):1–4. https://doi.org/10.1093/mutage/gew066
Sayes CM, Reed KL, Subramoney S, Abrams L, Warheit DB (2009) Can in vitro assays substitute for in vivo studies in assessing the pulmonary hazards of fine and nanoscale materials. J Nanopart Res 11(2):421–431. https://doi.org/10.1007/s11051-008-9471-3
Ahmed SA, Gogal RM Jr, Walsh JE (1994) A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 170(2):211–224
Kroll A, Pillukat MH, Hahn D, Schnekenburger J (2012) Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol 86(7):1123–1136. https://doi.org/10.1007/s00204-012-0837-z
Ponti J, Kinser-Ovaskainen A, Norlen H, Altmeyer S, Andreoli C, Bogni A, Chevillard S, De Angelis I, Chung S-T, Eom I, al. e (2014) Interlaboratory comparison study of the Colony Forming Efficiency assay for assessing cytotoxicity of nanomaterials. JRC Sci Policy Rep (JRC92910). doi:https://doi.org/10.2788/406937
Coradeghini R, Gioria S, Garcia CP, Nativo P, Franchini F, Gilliland D, Ponti J, Rossi F (2013) Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol Lett 217(3):205–216. https://doi.org/10.1016/j.toxlet.2012.11.022
Locatelli E, Broggi F, Ponti J, Marmorato P, Franchini F, Lena S, Franchini MC (2012) Lipophilic silver nanoparticles and their polymeric entrapment into targeted-PEG-based micelles for the treatment of glioblastoma. Adv Healthc Mater 1(3):342–347. https://doi.org/10.1002/adhm.201100047
El Yamani N, Collins AR, Runden-Pran E, Fjellsbo LM, Shaposhnikov S, Zienolddiny S, Dusinska M (2017) In vitro genotoxicity testing of four reference metal nanomaterials, titanium dioxide, zinc oxide, cerium oxide and silver: towards reliable hazard assessment. Mutagenesis 32(1):117–126. https://doi.org/10.1093/mutage/gew060
De Angelis I, Barone F, Zijno A, Bizzarri L, Russo MT, Pozzi R, Franchini F, Giudetti G, Uboldi C, Ponti J, Rossi F, De Berardis B (2013) Comparative study of ZnO and TiO(2) nanoparticles: physicochemical characterisation and toxicological effects on human colon carcinoma cells. Nanotoxicology 7(8):1361–1372. https://doi.org/10.3109/17435390.2012.741724
Fenoglio I, Ponti J, Alloa E, Ghiazza M, Corazzari I, Capomaccio R, Rembges D, Oliaro-Bosso S, Rossi F (2013) Singlet oxygen plays a key role in the toxicity and DNA damage caused by nanometric TiO2 in human keratinocytes. Nanoscale 5(14):6567–6576. https://doi.org/10.1039/c3nr01191g
Uboldi C, Giudetti G, Broggi F, Gilliland D, Ponti J, Rossi F (2012) Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts. Mutat Res 745(1–2):11–20. https://doi.org/10.1016/j.mrgentox.2011.10.010
Ponti J, Colognato R, Rauscher H, Gioria S, Broggi F, Franchini F, Pascual C, Giudetti G, Rossi F (2010) Colony Forming Efficiency and microscopy analysis of multi-wall carbon nanotubes cell interaction. Toxicol Lett 197(1):29–37. https://doi.org/10.1016/j.toxlet.2010.04.018
Haase A, Dommershausen N, Schulz M, Landsiedel R, Reichardt P, Krause BC, Tentschert J, Luch A (2017) Genotoxicity testing of different surface-functionalized SiO2, ZrO2 and silver nanomaterials in 3D human bronchial models. Arch Toxicol 91(12):3991–4007. https://doi.org/10.1007/s00204-017-2015-9
Riebeling C, Piret J-P, Trouiller B, Nelissen I, Saout C, Toussaint O, Haase A (2018) A guide to nanosafety testing: Considerations on cytotoxicity testing in different cell models. NanoImpact 10:1–10. https://doi.org/10.1016/j.impact.2017.11.004
Siegrist KJ, Reynolds SH, Kashon ML, Lowry DT, Dong C, Hubbs AF, Young SH, Salisbury JL, Porter DW, Benkovic SA, McCawley M, Keane MJ, Mastovich JT, Bunker KL, Cena LG, Sparrow MC, Sturgeon JL, Dinu CZ, Sargent LM (2014) Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses. Part Fibre Toxicol 11:6. https://doi.org/10.1186/1743-8977-11-6
OECD (1997) Test no. 471: bacterial reverse mutation test. OECD, Paris
Doak SH, Manshian B, Jenkins GJ, Singh N (2012) In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. Mutat Res 745(1–2):104–111. https://doi.org/10.1016/j.mrgentox.2011.09.013
Wang JJ, Sanderson BJ, Wang H (2007) Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutat Res 628(2):99–106. https://doi.org/10.1016/j.mrgentox.2006.12.003
Huk A, Izak-Nau E, Reidy B, Boyles M, Duschl A, Lynch I, Dusinska M (2014) Is the toxic potential of nanosilver dependent on its size? Part Fibre Toxicol 11:65. https://doi.org/10.1186/s12989-014-0065-1
Huk A, Izak-Nau E, El Yamani N, Uggerud H, Vadset M, Zasonska B, Duschl A, Dusinska M (2015) Impact of nanosilver on various DNA lesions and HPRT gene mutations—effects of charge and surface coating. Part Fibre Toxicol 12:25. https://doi.org/10.1186/s12989-015-0100-x
Gabelova A, El Yamani N, Alonso TI, Buliakova B, Srancikova A, Babelova A, Pran ER, Fjellsbo LM, Elje E, Yazdani M, Silva MJ, Dusinska M (2017) Fibrous shape underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry affects the biosafety of iron oxide nanoparticles. Mutagenesis 32(1):193–202. https://doi.org/10.1093/mutage/gew045
OECD. Test no. 476: in vitro mammalian cell gene mutation test. OECD, Paris
OECD. Test no. 490: in vitro mammalian cell gene mutation tests using the thymidine kinase gene. OECD, Paris
Moore MM, Honma M, Clements J, Awogi T, Bolcsfoldi G, Cole J, Gollapudi B, Harrington-Brock K, Mitchell A, Muster W, Myhr B, O'Donovan M, Ouldelhkim MC, San R, Shimada H, Stankowski LF Jr (2000) Mouse lymphoma thymidine kinase locus gene mutation assay: international workshop on genotoxicity test procedures workgroup report. Environ Mol Mutagen 35(3):185–190
Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Delongchamp R, Durward R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Lloyd M, Majeska J, Myhr B, O'Donovan M, Omori T, Riach C, San R, Stankowski LF Jr, Thakur AK, Van Goethem F, Wakuri S, Yoshimura I (2006) Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the international workshop on genotoxicity testing—Aberdeen, Scotland, 2003—assay acceptance criteria, positive controls, and data evaluation. Environ Mol Mutagen 47(1):1–5. https://doi.org/10.1002/em.20159
Cheng TF, Patton GW, Muldoon-Jacobs K (2013) Can the L5178Y Tk+/− mouse lymphoma assay detect epigenetic silencing? Food and chemical toxicology: an international journal published for the. British Industrial Biological Research Association 59:187–190. https://doi.org/10.1016/j.fct.2013.06.007
Clements J (2000) The mouse lymphoma assay. Mutat Res 455(1–2):97–110
Cowie H, Magdolenova Z, Saunders M, Drlickova M, Correia Carreira S, Halamoda Kenzaoi B, Gombau L, Guadagnini R, Lorenzo Y, Walker L, Fjellsbo LM, Huk A, Rinna A, Tran L, Volkovova K, Boland S, Juillerat-Jeanneret L, Marano F, Collins AR, Dusinska M (2015) Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles. Nanotoxicology 9(Suppl 1):57–65. https://doi.org/10.3109/17435390.2014.940407
Collins A, El Yamani N, Dusinska M (2017) Sensitive detection of DNA oxidation damage induced by nanomaterials. Free Radic Biol Med 107:69–76. https://doi.org/10.1016/j.freeradbiomed.2017.02.001
Dusinska M (1996) Detection of oxidised purines and UV induced photoproducts in DNA of single cells, by inclusion of lesion-specific enzymes in the comet assay. Alternat Lab Anim 24:405–411
OECD. Test no. 489: in vivo mammalian alkaline comet assay. OECD, Paris
Aardema MJ, Barnett BC, Khambatta Z, Reisinger K, Ouedraogo-Arras G, Faquet B, Ginestet AC, Mun GC, Dahl EL, Hewitt NJ, Corvi R, Curren RD (2010) International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility. Mutat Res 701(2):123–131. https://doi.org/10.1016/j.mrgentox.2010.05.017
Reus AA, Reisinger K, Downs TR, Carr GJ, Zeller A, Corvi R, Krul CA, Pfuhler S (2013) Comet assay in reconstructed 3D human epidermal skin models—investigation of intra- and inter-laboratory reproducibility with coded chemicals. Mutagenesis 28(6):709–720. https://doi.org/10.1093/mutage/get051
Collins AR, Dusinska M, Gedik CM, Stetina R (1996) Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 104(Suppl 3):465–469
Magdolenova Z, Lorenzo Y, Collins A, Dusinska M (2012) Can standard genotoxicity tests be applied to nanoparticles? J Toxicol Environ Health A 75(13–15):800–806. https://doi.org/10.1080/15287394.2012.690326
Karlsson HL, Di Bucchianico S, Collins AR, Dusinska M (2015) Can the comet assay be used reliably to detect nanoparticle-induced genotoxicity? Environ Mol Mutagen 56(2):82–96. https://doi.org/10.1002/em.21933
Azqueta A, Dusinska M (2015) The use of the comet assay for the evaluation of the genotoxicity of nanomaterials. Front Genet 6:239. https://doi.org/10.3389/fgene.2015.00239
Karlsson HL (2010) The comet assay in nanotoxicology research. Anal Bioanal Chem 398(2):651–666. https://doi.org/10.1007/s00216-010-3977-0
Collins AR, Annangi B, Rubio L, Marcos R, Dorn M, Merker C, Estrela-Lopis I, Cimpan MR, Ibrahim M, Cimpan E, Ostermann M, Sauter A, Yamani NE, Shaposhnikov S, Chevillard S, Paget V, Grall R, Delic J, de-Cerio FG, Suarez-Merino B, Fessard V, Hogeveen KN, Fjellsbo LM, Pran ER, Brzicova T, Topinka J, Silva MJ, Leite PE, Ribeiro AR, Granjeiro JM, Grafstrom R, Prina-Mello A, Dusinska M (2017) High throughput toxicity screening and intracellular detection of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9(1). https://doi.org/10.1002/wnan.1413
Final Report NanoGenoTox (2013) https://www.anses.fr/en/content/nanogenotox-final-report
Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455(1–2):81–95
OECD. Test no. 487: in vitro mammalian cell micronucleus test. OECD, Paris
Fenech M, Morley A (1985) Solutions to the kinetic problem in the micronucleus assay. Cytobios 43(172–173):233–246
Gonzalez L, Sanderson BJ, Kirsch-Volders M (2011) Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. Mutagenesis 26(1):185–191. https://doi.org/10.1093/mutage/geq088
Dahl EL, Curren R, Barnett BC, Khambatta Z, Reisinger K, Ouedraogo G, Faquet B, Ginestet AC, Mun G, Hewitt NJ, Carr G, Pfuhler S, Aardema MJ (2011) The reconstructed skin micronucleus assay (RSMN) in EpiDerm: detailed protocol and harmonized scoring atlas. Mutat Res 720(1–2):42–52. https://doi.org/10.1016/j.mrgentox.2010.12.001
Wolf T, Niehaus-Rolf C, Banduhn N, Eschrich D, Scheel J, Luepke NP (2008) The hen’s egg test for micronucleus induction (HET-MN): novel analyses with a series of well-characterized substances support the further evaluation of the test system. Mutat Res 650(2):150–164. https://doi.org/10.1016/j.mrgentox.2007.11.009
Hothorn LA, Reisinger K, Wolf T, Poth A, Fieblinger D, Liebsch M, Pirow R (2013) Statistical analysis of the hen's egg test for micronucleus induction (HET-MN assay). Mutat Res 757(1):68–78. https://doi.org/10.1016/j.mrgentox.2013.04.023
Dusinska M, Tulinska J, El Yamani N, Kuricova M, Liskova A, Rollerova E, Runden-Pran E, Smolkova B (2017) Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing? Food and chemical toxicology : an international journal published for the British Industrial. Biol Res Assoc 109(Pt 1):797–811. https://doi.org/10.1016/j.fct.2017.08.030
Sasaki K, Mizusawa H, Ishidate M (1988) Isolation and characterization of ras-transfected BALB/3T3 clone showing morphological transformation by 12-O-tetradecanoyl-phorbol-13-acetate. Jpn J Cancer Res 79(8):921–930
Sasaki K, Umeda M, Sakai A, Yamazaki S, Tanaka N (2015) Transformation assay in Bhas 42 cells: a model using initiated cells to study mechanisms of carcinogenesis and predict carcinogenic potential of chemicals. J Environ Sci Health C Environ Carcinogen Ecotoxicol Rev 33(1):1–35. https://doi.org/10.1080/10590501.2014.967058
Al-Nasiry S, Geusens N, Hanssens M, Luyten C, Pijnenborg R (2007) The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22(5):1304–1309. https://doi.org/10.1093/humrep/dem011
Lloyd M, Kidd D (2012) The mouse lymphoma assay. In: Parry JM, Parry EM (eds) Genetic toxicology: principles and methods. Humana, New York, NY, pp 35–54
Lovell DP, Omori T (2008) Statistical issues in the use of the comet assay. Mutagenesis 23(3):171–182. https://doi.org/10.1093/mutage/gen015
Bright J, Aylott M, Bate S, Geys H, Jarvis P, Saul J, Vonk R (2011) Recommendations on the statistical analysis of the comet assay. Pharm Stat 10(6):485–493. https://doi.org/10.1002/pst.530
Doak SH, Griffiths SM, Manshian B, Singh N, Williams PM, Brown AP, Jenkins GJ (2009) Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24(4):285–293. https://doi.org/10.1093/mutage/gep010
Prasad RY, Wallace K, Daniel KM, Tennant AH, Zucker RM, Strickland J, Dreher K, Kligerman AD, Blackman CF, Demarini DM (2013) Effect of treatment media on the agglomeration of titanium dioxide nanoparticles: impact on genotoxicity, cellular interaction, and cell cycle. ACS Nano 7(3):1929–1942. https://doi.org/10.1021/nn302280n
Li Y, Doak SH, Yan J, Chen DH, Zhou M, Mittelstaedt RA, Chen Y, Li C, Chen T (2017) Factors affecting the in vitro micronucleus assay for evaluation of nanomaterials. Mutagenesis 32(1):151–159. https://doi.org/10.1093/mutage/gew040
Elhajouji A, Cunha M, Kirsch-Volders M (1998) Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 13(2):193–198
Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534(1–2):65–75
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Dusinska, M. et al. (2019). In Vitro Approaches for Assessing the Genotoxicity of Nanomaterials. In: Zhang, Q. (eds) Nanotoxicity. Methods in Molecular Biology, vol 1894. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8916-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8916-4_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8915-7
Online ISBN: 978-1-4939-8916-4
eBook Packages: Springer Protocols